- Home
- APVO vs STAI Comparison
APVO vs STAI Comparison
Compare APVO & STAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APVO
- STAI
- Stock Information
- Founded
- APVO 2016
- STAI 2011
- Country
- APVO United States
- STAI United States
- Employees
- APVO N/A
- STAI N/A
- Industry
- APVO Biotechnology: Pharmaceutical Preparations
- STAI
- Sector
- APVO Health Care
- STAI
- Exchange
- APVO Nasdaq
- STAI Nasdaq
- Market Cap
- APVO 21.7M
- STAI 24.6M
- IPO Year
- APVO N/A
- STAI N/A
- Fundamental
- Price
- APVO $1.46
- STAI $0.59
- Analyst Decision
- APVO
- STAI
- Analyst Count
- APVO 0
- STAI 0
- Target Price
- APVO N/A
- STAI N/A
- AVG Volume (30 Days)
- APVO 4.5M
- STAI 15.0M
- Earning Date
- APVO 11-10-2025
- STAI 09-17-2025
- Dividend Yield
- APVO N/A
- STAI N/A
- EPS Growth
- APVO N/A
- STAI N/A
- EPS
- APVO N/A
- STAI N/A
- Revenue
- APVO N/A
- STAI $1,249,524.00
- Revenue This Year
- APVO N/A
- STAI N/A
- Revenue Next Year
- APVO N/A
- STAI N/A
- P/E Ratio
- APVO N/A
- STAI N/A
- Revenue Growth
- APVO N/A
- STAI 139.30
- 52 Week Low
- APVO $1.32
- STAI $0.35
- 52 Week High
- APVO $298.00
- STAI $9.07
- Technical
- Relative Strength Index (RSI)
- APVO 42.13
- STAI 56.18
- Support Level
- APVO $1.48
- STAI $0.48
- Resistance Level
- APVO $1.57
- STAI $0.73
- Average True Range (ATR)
- APVO 0.09
- STAI 0.10
- MACD
- APVO 0.00
- STAI 0.01
- Stochastic Oscillator
- APVO 0.00
- STAI 33.49
About APVO Aptevo Therapeutics Inc.
Aptevo Therapeutics Inc is a clinical-stage research and development biotechnology company focused on developing novel immunotherapeutic candidates for the treatment of different forms of cancer. Its clinical candidates are; ALG.APV-527, which targets co-stimulatory receptors and tumor antigens, and CD3xCD123, which is being developed as a potential treatment of frontline acute myelogenous leukemia. The company's preclinical candidates, APVO711, APVO0442, and APVO603, are being developed using the ADAPTIR modular protein technology platform. The company's versatile and robust ADAPTIR and ADAPTIR-FLEX platforms are designed to generate monospecific, bispecific, and multi-specific antibody candidates that are capable of enhancing the human immune system against cancer cells.
About STAI ScanTech AI Systems Inc. Common stock
ScanTech AI Systems Inc is developing and deploying security screening systems that protect travelers and other public members from criminals, terrorists, and other bad actors. It has developed a proprietary Computed Tomography scanning system that uses fixed-gantry technology to detect explosives, weapons, narcotics, and other contraband.